Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
doi: 10.1111/j.1442-2042.2011.02791.x
iju_2791
570..575
Objective: To evaluate the clinical usefulness of effective renal plasma ow (ERPF) measured using preoperative
mercaptoacetyltriglycine-3 (MAG3) renogram for the prediction of chronic renal insufciency after nephrectomy.
Methods: A total of 47 patients underwent preoperative MAG3 renal scintigraphy and subsequent unilateral nephrectomy. Correlations between the 5-year postoperative estimated glomerular ltration rate (eGFR) and the preoperative ERPF
of the contralateral kidney (cERPF), ERPF of the diseased kidney (dERPF), total ERPF (tERPF), cERPF to dERPF ratio, serum
creatinine (sCr) level, eGFR, as well as the inuence of preoperative comorbidities (diabetes, hypertension) on the postoperative eGFR, were evaluated with both univariate and multivariate analyses.
Results: Multiple linear regression analysis showed that preoperative cERPF signicantly correlated with postoperative
eGFR. However, a much stronger correlation was observed between the preoperative and postoperative eGFR. Multiple
logistic regression analysis showed that only preoperative eGFR was a signicant predicator of the development of
advanced-stage chronic kidney disease (CKD).
Conclusions: Preoperative MAG3 renogram is not superior to eGFR measurement as a prognostic indicator of long-term
renal function after unilateral nephrectomy.
Key words: chronic kidney disease, mercaptoacetyltriglycine-3 renogram, nephrectomy.
Introduction
Methods
Patients
MAG3 renogram
After an intravenous injection of 333 MBq of technetium99m-mercaptoacetyltriglycine (99mTc-MAG3), a renal scan
was carried out using a gamma-camera (Forte; ADAC, Milpitas, CA, USA). The MAG3 plasma clearance was calculated based on the renal uptake of 99m-Tc-MAG3 from 1 to
2011 The Japanese Urological Association
sCr (mg/dL)
eGFR (mL/min/1.73 m2)
cERPF (mL/min/1.73 m2)
dERPF (mL/min/1.73 m2)
tERPF (mL/min/1.73 m2)
cERPF to dERPF ratio
5-Year postoperative
Range
Mean
Range
Mean
0.483.04
12.5112.4
65.3408.1
33.0323.8
125.5732.0
0.777.91
0.96*
64.8**
213.7
156.1
369.7
1.87
0.788.94
3.873.6
1.41*
45.6**
*P = 0.001; **P = 0.0001. cERPF, effective renal plasma ow of the contralateral kidney; dERPF, effective renal plasma ow of the
diseased kidney; tERPF, total effective renal plasma ow; eGFR, estimated glomerular ltration rate; sCr, serum creatinine.
eGFR
Serum creatinine (sCr) was measured before the surgery and
5 years later. The eGFR levels were calculated using the
following formula, which was developed by the Japanese
Society of Nephrology:10 eGFR = 194 sCr-1.094 age-0.287
(0.739 if female).
Statistics
We used the paired t-test to compare the differences between
preoperative and postoperative renal parameters (sCr and
eGFR). Students t-test was used to compare postoperative
eGFR between patients with and without preoperative
comorbidities. The correlations between preoperative renal
parameters and postoperative eGFR were analyzed using
Pearsons correlation test. Multiple linear regression analysis was carried out to evaluate the contribution of preoperative renal parameters to predicting postoperative eGFR.
Logistic regression analysis was carried out to evaluate the
preoperative parameters used to predict advanced-stage
CKD (eGFR <30 mL/min/1.73 m2). A P-value of 0.05 was
considered to be statistically significant. The data were analyzed using the Statistical Package for Social Systems software, version 17.0 for Windows (SPSS, Chicago, IL, USA).
Results
The mean value and range of preoperative renal parameters
(sCr, cERPF, dERPF, tERPF, cERPF to dERPF ratio and
2011 The Japanese Urological Association
Diabetes mellitus
+
No.
Mean postoperative
eGFR (mL/min/1.73 m2)
20
27
39.6
50.0
0.014
8
39
38.0
47.1
0.213
P-value
H KANAMARU ET AL.
(b)
(a)
80
60
60
40
40
r = 0.421
P = 0.003
20
r = 0.515
P = 0.0001
20
0
100
200
300
Preop cERPF (mL/min/1.73m2)
400
(c)
100
200
300
Preop dERPF (mL/min/1.73m2)
400
(d)
Postop eGFR (mL/min/1.73m2)
80
80
r = 0.260
P = 0.077
60
60
40
40
r = 0.566
P = 0.0001
20
0
100
200
300
400
500
600
Preop tERPF (mL/min/1.73m2)
700
(e)
20
800
4
6
Preop cERPF to dERPF ratio
(f)
Postop eGFR (mL/min/1.73m2)
80
80
r = 0.672
P = 0.0001
60
60
40
40
20
20
r = 0.798
P = 0.0001
0
0
2
Preop sCr (mg/dL)
20
40
60
80
Preop eGFR (mL/min/1.73m2)
100
120
Fig. 1 (a) Correlation between preoperative effective renal plasma ow (ERPF) of the contralateral kidney (cERPF) and 5-year
postoperative estimated glomerular ltration rate (eGFR). (b) Correlation between preoperative ERPF of the diseased kidney (dERPF)
and 5-year postoperative eGFR. (c) Correlation between preoperative total ERPF (tERPF) and 5-year postoperative eGFR. (d) Correlation between preoperative cERPF to dERPF ratio and 5-year postoperative eGFR. (e) Correlation between preoperative serum
creatinine (sCr) and 5-year postoperative eGFR. (f) Correlation between preoperative eGFR and 5-year postoperative eGFR.
572
Table 3 Multivariate analysis of the predictive factors for 5-year postoperative estimated glomerular ltration rate
Statistical method
Dependent variable
Independent variable
Odds ratio
P-value
95% CI
Postoperative eGFR
(continuous variable)
Postoperative eGFR
(<30 mL/min/1.73 m2 vs
30 mL/min/1.73 m2)
Preoperative eGFR
Preoperative cERPF
Preoperative eGFR
0.510
0.048
1.086
0.0001
0.0080
0.017
0.3890.630
0.0130.084
1.0151.162
cERPF, effective renal plasma ow of the contralateral kidney; eGFR, estimated glomerular ltration rate.
Discussion
Recent comparative studies have reported that nephrectomy
is associated with a greater decrease in renal function than
nephron sparing surgery.36 The treatment strategy for small
renal cell carcinoma, therefore, has shifted toward nephron
sparing surgery instead of total nephrectomy.11 However,
nephrectomy will continue to be a treatment option, not only
for renal cell cancer, but also for other renal diseases. When
nephrectomy is planned for a patient, urologists have to
make a careful decision of whether surgery is associated
with a high risk of chronic renal insufficiency in that patient.
At the current time, the method of preoperative renal function assessment is not standardized. Although renal scintigraphy is an effective modality to evaluate differential renal
function, a recent survey of the American Urological Association showed that it is carried out less commonly as compared with other renal function tests.12
In the present study, we evaluated the usefulness of a
preoperative MAG3 renogram for the prediction of renal
function 5 years after nephrectomy. As shown here, the
cERPF to dERPF ratio ranged widely from 0.77 to 7.91,
which showed that the impact of the loss of one renal unit on
the postoperative renal function of the other would vary in
individual cases. We therefore expected that the preoperative
evaluation of contralateral (not to be removed) kidney func 2011 The Japanese Urological Association
H KANAMARU ET AL.
References
1 McKiernan J, Simmons R, Katz J, Russo P. Natural history
of chronic renal insufficiency after partial and radical
nephrectomy. Urology 2002; 59: 81620.
2 Najarian JS, McHugh LE, Matas AJ, Chavers BM. 20 years
or more of follow-up of living kidney donors. Lancet 1992;
340: 80710.
3 Malcolm JB, Bagrodia A, Derweesh IH et al. Comparison
of rates and risk factors for developing chronic renal
insufficiency, proteinuria and metabolic acidosis after
radical or partial nephrectomy. BJU Int. 2009; 104:
47681.
4 Lucas SM, Stern JM, Adibi M, Zeltser IS, Cadeddu JA, Raj
GV. Renal function outcomes in patients treated for renal
masses smaller than 4 cm by ablative and extirpative
techniques. J. Urol. 2008; 179: 7580.
5 Weight CJ, Larson BT, Fergany AF et al. Nephrectomy
induced chronic renal insufficiency is associated with
increased risk of cardiovascular death and death from any
cause in patients with localized cT1b renal masses. J. Urol.
2010; 183: 131723.
574